Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Invesco Solar ETF
TAN
4
Direxion Daily Energy Bull 2X Shares ETF
ERX
5
The Technology Select Sector SPDR® Fund
XLK
US Stock MarketDetailed Quotes
SkinHealth Systems (SKIN)
- 0.6437
- -0.0332-4.90%
Close May 15 16:00 ET
- 0.6437
- 0.00000.00%
Post 16:10 ET
83.42MMarket Cap-4.95P/E (TTM)
0.6900High0.6143Low775.74KVolume0.6529Open0.6769Prev Close495.13KTurnover1.19%Turnover RatioLossP/E (Static)129.60MShares2.690052wk High1.51P/B41.85MFloat Cap0.550652wk Low--Dividend TTM65.01MShs Float30.1727Historical High--Div Yield TTM11.18%Range %0.5506Historical Low0.6383Avg Price1Lot Size
SKIN Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
SKIN Orderflow
Unit: --
SKIN Orderflow Trend
IntradayDayWeekMonth
No Data
SkinHealth Systems (SKIN) News
Beauty Health Receives Nasdaq Notice on Bid Price
Rebranding Risk: How SkinHealth Systems' Name Change Could Erode Brand Equity, Raise Marketing Costs, and Pressure Margins
CCORF Maintains SkinHealth Systems(SKIN.US) With Hold Rating, Maintains Target Price $1
Beauty Health (SKIN) Receives a Hold From Canaccord Genuity
SkinHealth Systems Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results and Lowered Its FY2026 Sales Guidance Below Estimates.
Express News | SkinHealth Systems Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results and Lowered Its FY2026 Sales Guidance Below Estimates
SkinHealth Systems (SKIN) Stock Forum
$Dermata Therapeutics (DRMA.US)$
Bullish Equity Research Report
Dermata Therapeutics, Inc. (NASDAQ: DRMA)
Date: February 11, 2026
Current Price: $1.69
Shares Outstanding: ~3.2 Million
Cash Balance: Over $8 Million
Analyst Coverage: Strong Buy – $10 Price Target
🚀 Investment Thesis
Dermata Therapeutics (DRMA) is approaching a potential major inflection point as it transitions from a development-stage biotech into a commercial-stage OTC dermatology company targeting the ...
Bullish Equity Research Report
Dermata Therapeutics, Inc. (NASDAQ: DRMA)
Date: February 11, 2026
Current Price: $1.69
Shares Outstanding: ~3.2 Million
Cash Balance: Over $8 Million
Analyst Coverage: Strong Buy – $10 Price Target
🚀 Investment Thesis
Dermata Therapeutics (DRMA) is approaching a potential major inflection point as it transitions from a development-stage biotech into a commercial-stage OTC dermatology company targeting the ...
28
16
1
$SkinHealth Systems (SKIN.US)$ Beauty Health Q3 Sales USD 70.7 Million Vs. IBES Estimate USD 68.6 Million
Nov 06 (Reuters) - Beauty Health Q3 Sales USD 70.7 Million Vs. IBES Estimate USD 68.6 Million.
Q3 Adjusted Ebitda USD 8.9 Million Vs. IBES Estimate USD 2.16 Million
Q3 Adjusted Gross Margin 68%
Nov 06 (Reuters) - Beauty Health Q3 Sales USD 70.7 Million Vs. IBES Estimate USD 68.6 Million.
Q3 Adjusted Ebitda USD 8.9 Million Vs. IBES Estimate USD 2.16 Million
Q3 Adjusted Gross Margin 68%
1
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)